Aytu Biopharma Tender Offer Seeks All Shares for $2.70 Cash Each
The cash tender offer is a corporate transaction involving all shares.
Story updates
10:03:59 PM UTC
SquawkNews
By Katherine HamiltonRosemont Pharmaceuticals has agreed to acquire Aytu BioPharma for $2.70 a share.The all-cash transaction is structured as a tender offer followed by a merger. It is worth about $29.3 million, based on Aytu's 10.87 million outstanding shares.Aytu will tender shares representing…